Literature DB >> 237318

Genetic control of the in vitro responses of rat blood lymphocytes. I. Comparison of in vitro and in vivo responses.

H E Nielsen, C Koch.   

Abstract

Nielsen, H. E. & Koch, C. Genetic Control of the In Vitro Responses of Rat Blood Lymphocytes. I. Comparison of In Vitro and In Vivo Responses, Scand. J. Immunol. 4, 31-36, 1975. In vitro DNA synthetic responses of blood lymphocytes from the inbred rat strains BN, Lewis, and AS were compared with each other after stimulation with allogeneic lymphocytes, human lymphocytes, phytohemagglutinin, and anti-Ig antibodies. BN lymphocytes responded less well than AS and Lewis lymphocytes regardless of the stimulus used. The responses of the congenic strains Lewis and Lewis. BN were identical, suggesting that H-1 (Ag-B)-linked loci do not determine in vitro responsiveness in these strains. In vivo, AS and BN rats were equally able to reject third-party skin grafts and to induce graft-versus-host reactions in F1 hybrids. We conclude that the interstrain differences found in vitro reflect genetically determined differences in in vitro kinetics, possibly related to the fraction of short-lived lymphocytes present rather than to demonstrable differences in the frequency of reactive lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 237318     DOI: 10.1111/j.1365-3083.1975.tb02597.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

1.  Dence for a gene in rats affecting lymphocyte responsiveness to PHA.

Authors:  D L Gasser; B A Winters; G Balaban-Malenbaum
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

Review 2.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

3.  Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.

Authors:  B S Shine; J Hungerford; B Vaghela; G A Sheraidah
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.